← Leaderboards
A. Stewart Campbell
Ancora Pharmaceuticals, Inc.
$530,977
Attributed
$530,977
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $266.9K · FY2009–10$500K$375K$250K$125K$0
'09
'10
Funding mix
By agency
NIH$530,977 · 1
By mechanism
R43$530,977 · 1
Top collaborators
No co-investigators on record.
Most similar at Ancora Pharmaceuticals, Inc.
Same institution · by research overlap
- William J Christ$3,320,986
- Obadiah Plante$562,998
Others in their field
Top investigators on “Alhydrogel”
- Gary R. Matyas · Henry M. Jackson Fdn For The Adv Mil/Med$7,763,899
- Sukjoon Park · Emergent Product Development Gaithersbur$5,351,252
- David Joseph Diemert · George Washington University$4,367,462
- John H Eldridge · University Of Alabama At Birmingham$4,179,349
- Jonathan D. Kurtis · Brown University$3,925,570
- Allan Watkinson · Avecia Biologics, Ltd$2,999,760
Research focus
AlhydrogelAluminumAnalogAnemiaAnimal ModelAnimalsAntigensAntimalarialsBaseBiological ModelsBloodBlood CellsBone MarrowCarbohydratesCarrier ProteinsCellsCerebral MalariaCessation Of LifeChildClinically RelevantClinical Trials DesignComplicationConjugated CarrierAdjuvant